Zhang Ming, Zhou Sheng-hua, Li Xu-ping, Shen Xiang-Qian, Fang Zhen-fei
Department of Cardiology, Second Xiangya Hospital, Central South University, Changsha Hunan 410011, China.
Med Hypotheses. 2008;70(4):838-41. doi: 10.1016/j.mehy.2007.06.041. Epub 2007 Oct 24.
Recent findings demonstrate the vital role of endothelial progenitor cells in the homeostasis of the vessel wall and the development of atherosclerosis. Endothelial progenitor cells (EPCs) play important roles in repair-to-injury of arteries. Many evidences have shown Cardiovascular risk factors closely correlated with EPCs numbers and function. Levels of circulating EPCs represented a better predictor of endothelial function than conventional risk factors. Depletion of bone marrow and Cardiovascular risk factors are the two prerequisits of atherosclerosis. All conditions of manifest atherosclerotic disease are accompanied by reduced EPC numbers and migratory capacity. Therefore, based on response-to-injury hypothesis and these findings, we build up EPCs-mediated repair-to-injury hypothesis, which may have important therapeutic implications in the prevention and therapy of atherosclerosis. The use of EPCs for vascular repair may be important therapy strategies with a maximized benefit for the patient in the future.
最近的研究结果表明,内皮祖细胞在血管壁稳态和动脉粥样硬化发展中起着至关重要的作用。内皮祖细胞(EPCs)在动脉损伤修复中发挥重要作用。许多证据表明心血管危险因素与EPCs数量和功能密切相关。循环EPCs水平比传统危险因素更能预测内皮功能。骨髓耗竭和心血管危险因素是动脉粥样硬化的两个先决条件。所有明显的动脉粥样硬化疾病状态都伴随着EPCs数量减少和迁移能力下降。因此,基于损伤反应假说和这些发现,我们建立了EPCs介导的损伤修复假说,这可能对动脉粥样硬化的预防和治疗具有重要的治疗意义。使用EPCs进行血管修复可能是未来对患者益处最大化的重要治疗策略。